- Book
- June 2024
- 496 Pages
- Book
- April 2024
- 304 Pages
- Book
- November 2022
- 208 Pages
- Book
- September 2022
- 304 Pages
- Book
- January 2021
- 352 Pages
- Book
- December 2019
- 432 Pages
- Book
- January 2019
- 264 Pages
- Book
- January 2019
- 600 Pages
- Book
- January 2017
- 488 Pages
- Book
- January 2016
- 952 Pages
- Book
- May 2014
- 560 Pages
- Book
- April 2014
- 344 Pages
- Book
- April 2013
- 296 Pages
- Book
- November 2012
- 240 Pages
- Book
- June 2012
- 596 Pages
- Book
- April 2012
- 776 Pages
- Book
- November 2011
- 432 Pages
- Book
- March 2011
- 268 Pages
- Book
- November 2010
- 232 Pages
- Book
- April 2008
- 538 Pages

Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more